UniProt ID | GNAI2_HUMAN | |
---|---|---|
UniProt AC | P04899 | |
Protein Name | Guanine nucleotide-binding protein G(i) subunit alpha-2 | |
Gene Name | GNAI2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 355 | |
Subcellular Localization |
Cytoplasm . Cytoplasm, cytoskeleton, microtubule organizing center, centrosome . Cell membrane . Membrane Lipid-anchor . Localizes in the centrosomes of interphase and mitotic cells. Detected at the cleavage furrow and/or the midbody. |
|
Protein Description | Guanine nucleotide-binding proteins (G proteins) are involved as modulators or transducers in various transmembrane signaling systems. The G(i) proteins are involved in hormonal regulation of adenylate cyclase: they inhibit the cyclase in response to beta-adrenergic stimuli. May play a role in cell division.; Isoform sGi2: Regulates the cell surface density of dopamine receptors DRD2 by sequestrating them as an intracellular pool.. | |
Protein Sequence | MGCTVSAEDKAAAERSKMIDKNLREDGEKAAREVKLLLLGAGESGKSTIVKQMKIIHEDGYSEEECRQYRAVVYSNTIQSIMAIVKAMGNLQIDFADPSRADDARQLFALSCTAEEQGVLPDDLSGVIRRLWADHGVQACFGRSREYQLNDSAAYYLNDLERIAQSDYIPTQQDVLRTRVKTTGIVETHFTFKDLHFKMFDVGGQRSERKKWIHCFEGVTAIIFCVALSAYDLVLAEDEEMNRMHESMKLFDSICNNKWFTDTSIILFLNKKDLFEEKITHSPLTICFPEYTGANKYDEAASYIQSKFEDLNKRKDTKEIYTHFTCATDTKNVQFVFDAVTDVIIKNNLKDCGLF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Myristoylation | ------MGCTVSAED ------CCCCCCHHH | 18.79 | 22223895 | |
3 | S-palmitoylation | -----MGCTVSAEDK -----CCCCCCHHHH | 3.07 | - | |
4 | Phosphorylation | ----MGCTVSAEDKA ----CCCCCCHHHHH | 16.27 | 28258704 | |
6 | O-linked_Glycosylation | --MGCTVSAEDKAAA --CCCCCCHHHHHHH | 14.05 | 25367160 | |
6 | Phosphorylation | --MGCTVSAEDKAAA --CCCCCCHHHHHHH | 14.05 | 29083192 | |
16 | O-linked_Glycosylation | DKAAAERSKMIDKNL HHHHHHHHHHHCHHH | 20.34 | 25367160 | |
17 | Ubiquitination | KAAAERSKMIDKNLR HHHHHHHHHHCHHHH | 46.20 | - | |
21 | Acetylation | ERSKMIDKNLREDGE HHHHHHCHHHHHHHH | 47.13 | 25953088 | |
21 | Ubiquitination | ERSKMIDKNLREDGE HHHHHHCHHHHHHHH | 47.13 | - | |
29 | Acetylation | NLREDGEKAAREVKL HHHHHHHHHHHHHHH | 53.53 | 25953088 | |
29 | Ubiquitination | NLREDGEKAAREVKL HHHHHHHHHHHHHHH | 53.53 | 21906983 | |
29 (in isoform 1) | Ubiquitination | - | 53.53 | 21890473 | |
35 | Acetylation | EKAAREVKLLLLGAG HHHHHHHHHHEECCC | 28.76 | 25953088 | |
35 | Ubiquitination | EKAAREVKLLLLGAG HHHHHHHHHHEECCC | 28.76 | - | |
35 (in isoform 1) | Ubiquitination | - | 28.76 | 21890473 | |
35 (in isoform 2) | Ubiquitination | - | 28.76 | 21890473 | |
38 | Ubiquitination | AREVKLLLLGAGESG HHHHHHHEECCCCCC | 6.33 | - | |
44 | Phosphorylation | LLLGAGESGKSTIVK HEECCCCCCCCHHHH | 51.07 | 20873877 | |
46 | Ubiquitination | LGAGESGKSTIVKQM ECCCCCCCCHHHHEE | 54.42 | 21890473 | |
46 (in isoform 1) | Ubiquitination | - | 54.42 | 21890473 | |
47 | Phosphorylation | GAGESGKSTIVKQMK CCCCCCCCHHHHEEE | 27.22 | 20873877 | |
48 | Phosphorylation | AGESGKSTIVKQMKI CCCCCCCHHHHEEEE | 33.02 | 29514088 | |
51 | Ubiquitination | SGKSTIVKQMKIIHE CCCCHHHHEEEEECC | 40.60 | 21906983 | |
51 (in isoform 1) | Ubiquitination | - | 40.60 | 21890473 | |
54 | Acetylation | STIVKQMKIIHEDGY CHHHHEEEEECCCCC | 35.69 | 26051181 | |
54 | Ubiquitination | STIVKQMKIIHEDGY CHHHHEEEEECCCCC | 35.69 | - | |
61 | Phosphorylation | KIIHEDGYSEEECRQ EEECCCCCCHHHHHH | 25.82 | 25884760 | |
62 | Phosphorylation | IIHEDGYSEEECRQY EECCCCCCHHHHHHH | 44.02 | 26356563 | |
66 | S-palmitoylation | DGYSEEECRQYRAVV CCCCHHHHHHHHHHH | 3.58 | 29575903 | |
69 | Phosphorylation | SEEECRQYRAVVYSN CHHHHHHHHHHHCHH | 4.92 | 22817900 | |
88 | Sulfoxidation | IMAIVKAMGNLQIDF HHHHHHHHCCCEEEE | 2.79 | 21406390 | |
111 | O-linked_Glycosylation | ARQLFALSCTAEEQG HHHHHHHHCCHHHCC | 13.14 | 25367160 | |
112 | Glutathionylation | RQLFALSCTAEEQGV HHHHHHHCCHHHCCC | 4.32 | 22555962 | |
112 | S-palmitoylation | RQLFALSCTAEEQGV HHHHHHHCCHHHCCC | 4.32 | 29575903 | |
113 | O-linked_Glycosylation | QLFALSCTAEEQGVL HHHHHHCCHHHCCCC | 33.46 | 25367160 | |
125 | O-linked_Glycosylation | GVLPDDLSGVIRRLW CCCCCCHHHHHHHHH | 37.70 | 25367160 | |
141 | Ubiquitination | DHGVQACFGRSREYQ HHCHHHHCCCCCCEE | 11.61 | 21890473 | |
144 | Phosphorylation | VQACFGRSREYQLND HHHHCCCCCCEECCC | 29.82 | 22817900 | |
146 | Ubiquitination | ACFGRSREYQLNDSA HHCCCCCCEECCCCH | 38.59 | 21890473 | |
147 | Phosphorylation | CFGRSREYQLNDSAA HCCCCCCEECCCCHH | 19.72 | - | |
155 | Phosphorylation | QLNDSAAYYLNDLER ECCCCHHHHHHHHHH | 14.27 | - | |
156 | Ubiquitination | LNDSAAYYLNDLERI CCCCHHHHHHHHHHH | 8.36 | 21890473 | |
161 | Ubiquitination | AYYLNDLERIAQSDY HHHHHHHHHHHHCCC | 44.92 | 21890473 | |
168 | Phosphorylation | ERIAQSDYIPTQQDV HHHHHCCCCCCHHHH | 17.66 | 22817900 | |
177 | Ubiquitination | PTQQDVLRTRVKTTG CCHHHHHHHHHCCCC | 21.97 | 21890473 | |
177 (in isoform 2) | Ubiquitination | - | 21.97 | 21890473 | |
179 | ADP-ribosylation | QQDVLRTRVKTTGIV HHHHHHHHHCCCCEE | 22.85 | - | |
179 | ADP-ribosylation | QQDVLRTRVKTTGIV HHHHHHHHHCCCCEE | 22.85 | - | |
182 | Ubiquitination | VLRTRVKTTGIVETH HHHHHHCCCCEEEEE | 27.65 | 21890473 | |
182 (in isoform 2) | Ubiquitination | - | 27.65 | 21890473 | |
193 | Ubiquitination | VETHFTFKDLHFKMF EEEEEEECCEEEEEE | 57.21 | - | |
193 (in isoform 1) | Ubiquitination | - | 57.21 | 21890473 | |
193 | Ubiquitination | VETHFTFKDLHFKMF EEEEEEECCEEEEEE | 57.21 | 21890473 | |
197 | Ubiquitination | FTFKDLHFKMFDVGG EEECCEEEEEEECCC | 8.79 | 21890473 | |
198 | Acetylation | TFKDLHFKMFDVGGQ EECCEEEEEEECCCC | 28.10 | 26822725 | |
198 | Ubiquitination | TFKDLHFKMFDVGGQ EECCEEEEEEECCCC | 28.10 | - | |
198 (in isoform 1) | Ubiquitination | - | 28.10 | 21890473 | |
198 | Ubiquitination | TFKDLHFKMFDVGGQ EECCEEEEEEECCCC | 28.10 | 21890473 | |
205 | Deamidated glutamine | KMFDVGGQRSERKKW EEEECCCCCCCHHHH | 39.54 | - | |
205 | Deamidation | KMFDVGGQRSERKKW EEEECCCCCCCHHHH | 39.54 | 24141704 | |
207 | Phosphorylation | FDVGGQRSERKKWIH EECCCCCCCHHHHHH | 33.59 | 23401153 | |
212 | Ubiquitination | QRSERKKWIHCFEGV CCCCHHHHHHHHHHH | 6.65 | 21890473 | |
233 | Ubiquitination | VALSAYDLVLAEDEE HHHHHHHHHHHCHHH | 1.90 | 21890473 | |
233 (in isoform 2) | Ubiquitination | - | 1.90 | 21890473 | |
249 | Acetylation | NRMHESMKLFDSICN HHHHHHHHHHHHHHC | 56.11 | 25953088 | |
249 | Ubiquitination | NRMHESMKLFDSICN HHHHHHHHHHHHHHC | 56.11 | 21890473 | |
249 (in isoform 1) | Ubiquitination | - | 56.11 | 21890473 | |
249 | Ubiquitination | NRMHESMKLFDSICN HHHHHHHHHHHHHHC | 56.11 | 21890473 | |
253 | Phosphorylation | ESMKLFDSICNNKWF HHHHHHHHHHCCCCC | 23.00 | 20873877 | |
255 | Ubiquitination | MKLFDSICNNKWFTD HHHHHHHHCCCCCCC | 5.48 | 21890473 | |
256 | Ubiquitination | KLFDSICNNKWFTDT HHHHHHHCCCCCCCC | 51.99 | - | |
261 | Phosphorylation | ICNNKWFTDTSIILF HHCCCCCCCCEEEEE | 36.93 | 28857561 | |
263 | Phosphorylation | NNKWFTDTSIILFLN CCCCCCCCEEEEEEE | 20.83 | 28857561 | |
270 | Ubiquitination | TSIILFLNKKDLFEE CEEEEEEEHHHHHHH | 41.83 | 21890473 | |
272 | Ubiquitination | IILFLNKKDLFEEKI EEEEEEHHHHHHHHC | 59.60 | - | |
278 | Ubiquitination | KKDLFEEKITHSPLT HHHHHHHHCCCCCCE | 45.78 | - | |
280 | Ubiquitination | DLFEEKITHSPLTIC HHHHHHCCCCCCEEE | 27.63 | - | |
282 | Phosphorylation | FEEKITHSPLTICFP HHHHCCCCCCEEECC | 16.98 | 25627689 | |
291 | Ubiquitination | LTICFPEYTGANKYD CEEECCCCCCCCCHH | 15.65 | 21890473 | |
291 (in isoform 2) | Ubiquitination | - | 15.65 | 21890473 | |
296 | Acetylation | PEYTGANKYDEAASY CCCCCCCCHHHHHHH | 54.25 | 26051181 | |
296 | Ubiquitination | PEYTGANKYDEAASY CCCCCCCCHHHHHHH | 54.25 | - | |
297 | Ubiquitination | EYTGANKYDEAASYI CCCCCCCHHHHHHHH | 20.87 | - | |
297 | Phosphorylation | EYTGANKYDEAASYI CCCCCCCHHHHHHHH | 20.87 | 29978859 | |
299 | Ubiquitination | TGANKYDEAASYIQS CCCCCHHHHHHHHHH | 42.94 | - | |
302 | Ubiquitination | NKYDEAASYIQSKFE CCHHHHHHHHHHHHH | 29.80 | - | |
302 | Phosphorylation | NKYDEAASYIQSKFE CCHHHHHHHHHHHHH | 29.80 | 29978859 | |
303 | Phosphorylation | KYDEAASYIQSKFED CHHHHHHHHHHHHHH | 9.77 | 29978859 | |
306 | Phosphorylation | EAASYIQSKFEDLNK HHHHHHHHHHHHHHH | 29.74 | 29978859 | |
307 | Ubiquitination | AASYIQSKFEDLNKR HHHHHHHHHHHHHHC | 36.08 | 21890473 | |
307 (in isoform 1) | Ubiquitination | - | 36.08 | 21890473 | |
307 | Ubiquitination | AASYIQSKFEDLNKR HHHHHHHHHHHHHHC | 36.08 | 21890473 | |
313 | Ubiquitination | SKFEDLNKRKDTKEI HHHHHHHHCCCCCHH | 69.03 | - | |
315 | Ubiquitination | FEDLNKRKDTKEIYT HHHHHHCCCCCHHHH | 71.94 | - | |
318 | Ubiquitination | LNKRKDTKEIYTHFT HHHCCCCCHHHHHEE | 52.85 | - | |
321 | Phosphorylation | RKDTKEIYTHFTCAT CCCCCHHHHHEEECC | 8.68 | 28152594 | |
334 | Ubiquitination | ATDTKNVQFVFDAVT CCCCCCCEEEHHHHH | 37.87 | - | |
350 | Ubiquitination | VIIKNNLKDCGLF-- HHHHCCCCCCCCC-- | 53.77 | - | |
352 | ADP-ribosylation | IKNNLKDCGLF---- HHCCCCCCCCC---- | 4.95 | - | |
352 | ADP-ribosylation | IKNNLKDCGLF---- HHCCCCCCCCC---- | 4.95 | - | |
352 | S-palmitoylation | IKNNLKDCGLF---- HHCCCCCCCCC---- | 4.95 | 29575903 |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
205 | Q | Amidation |
| 24141704 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GNAI2_HUMAN !! |
loading...
Phosphorylation | |
Reference | PubMed |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-69, AND MASSSPECTROMETRY. |